Aptamer Group plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APTA.L research report →
Companyaptamergroup.com
Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes.
- CEO
- Arron Craig Tolley
- IPO
- 2021
- Employees
- 28
- HQ
- York, GB
Price Chart
Valuation
- Market Cap
- $16.57M
- P/E
- -6.06
- P/S
- 12.02
- P/B
- 6.61
- EV/EBITDA
- -6.43
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 31.79%
- Op Margin
- -197.31%
- Net Margin
- -178.52%
- ROE
- -135.35%
- ROIC
- -97.89%
Growth & Income
- Revenue
- $1.20M · 39.88%
- Net Income
- $-2,424,000 · 18.05%
- EPS
- $-0.00 · 80.28%
- Op Income
- $-2,697,000
- FCF YoY
- 16.42%
Performance & Tape
- 52W High
- $1.57
- 52W Low
- $0.30
- 50D MA
- $0.63
- 200D MA
- $0.83
- Beta
- 0.92
- Avg Volume
- 5.70M
Get TickerSpark's AI analysis on APTA.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our APTA.L Coverage
We haven't published any research on APTA.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate APTA.L Report →